carbenoxolone sodium has been researched along with Body Weight in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Islam, SA; Moon, SS; Seo, M | 1 |
| Al-Bader, MD; Jasem, SA; Kilarkaje, N | 1 |
| Du, H; Friedman, TC; Liu, L; Liu, Y; Lutfy, K; Nakagawa, Y; Ren, X; Wang, W; Wang, Y | 1 |
| Fujisawa, Y; Liu, YJ; Nagata, E; Nakagawa, Y; Nakanishi, T; Ohzeki, T; Sano, S; Satake, E; Yamaguchi, R | 1 |
| Halemani, PD; Mohan, CG; Rajendra, CE; Savinay, G; Viswanatha, GL | 1 |
| Langley-Evans, SC; McMullen, S | 1 |
| Hachey, DL; Hasty, AH; Nuotio-Antar, AM | 1 |
| Flatt, PR; Gault, VA; Irwin, N; McKillop, AM; Taylor, A | 1 |
| Ganguli, PC; Mohamed, SD | 1 |
| Baron, JH; Gribble, RJ; Holdstock, DJ; Lewis, SI; Murgatroyd, RE; Reed, PI; Vincent-Brown, A | 1 |
| Reissigl, H; Schwamberger, K | 1 |
| Brown, MA; Edwards, CR; Whitworth, JA; Williamson, PM | 1 |
| Classen, M; Hagenmüller, F; Wurbs, D | 1 |
| Falaiye, JM; Odutola, TA; Oladapo, JM | 1 |
| Armanini, D; Karbowiak, I; Lewicka, S; Mantero, F; Scali, M; Vecsei, P; Wallace, C; Zennaro, MC | 1 |
4 trial(s) available for carbenoxolone sodium and Body Weight
| Article | Year |
|---|---|
The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
Topics: Adult; Amiloride; Blood Pressure; Body Weight; Carbenoxolone; Clinical Trials as Topic; Double-Blind Method; Female; Glycyrrhetinic Acid; Humans; Male; Middle Aged; Pyrazines; Random Allocation; Stomach Ulcer | 1980 |
Carbenoxolone patients with gastric ulcers. A double-blind trial.
Topics: Adult; Body Weight; Carbenoxolone; Clinical Trials as Topic; Double-Blind Method; Edema; Female; Gastroscopy; Glycyrrhetinic Acid; Humans; Male; Potassium; Random Allocation; Stomach Ulcer | 1980 |
Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adult; Aldosterone; Blood Vessels; Body Weight; Carbenoxolone; Chlorides; Creatinine; Female; Hemodynamics; Humans; Hydroxysteroid Dehydrogenases; Kidney; Kidney Diseases; Male; Potassium; Renin; Sodium | 1994 |
Carbenoxolone sodium for gastric ulcer.
Topics: Benzothiadiazines; Body Weight; Carbenoxolone; Clinical Trials as Topic; Diuretics; Duodenal Ulcer; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Sodium Chloride Symporter Inhibitors; Spironolactone; Stomach Ulcer; Triterpenes | 1975 |
12 other study(ies) available for carbenoxolone sodium and Body Weight
| Article | Year |
|---|---|
Acute anti-obesity effects of intracerebroventricular 11β-HSD1 inhibitor administration in diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Anti-Obesity Agents; Body Weight; Carbenoxolone; Diet, High-Fat; Eating; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Hypothalamus; Injections, Intraventricular; Insulin; Leptin; Male; Mechanistic Target of Rapamycin Complex 1; Membrane Glycoproteins; Mice; Neurons; Obesity; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; X-Box Binding Protein 1 | 2018 |
Carbenoxolone exposure during late gestation in rats alters placental expressions of p53 and estrogen receptors.
Topics: Animals; Body Weight; Carbenoxolone; Cell Proliferation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation; Intracellular Space; Male; Maternal Exposure; Mothers; Pituitary Gland; Placenta; Pregnancy; Protein Transport; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Suppressor Protein p53 | 2016 |
Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Blood Glucose; Body Weight; Carbenoxolone; Carbohydrate Dehydrogenases; Cells, Cultured; Corticosterone; Deoxyglucose; Dietary Fats; Gene Expression; Glucose Tolerance Test; Hepatocytes; Homeostasis; Immunoblotting; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Receptors, Glucocorticoid; RNA, Messenger | 2008 |
Carbenoxolone alters the morphology of adipose tissues and downregulates genes involved in adipogenesis, glucose transport and lipid metabolism in high-fat diet-fed mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Biological Transport; Body Weight; Carbenoxolone; Diet, High-Fat; Down-Regulation; Feeding Behavior; Glucose; Glucose Tolerance Test; Insulin; Intra-Abdominal Fat; Lipid Metabolism; Lipogenesis; Male; Mice; Mice, Inbred BALB C; Organ Size; RNA, Messenger | 2012 |
1,2,3,4,6 Penta-O-galloyl-β-d-glucose, a bioactivity guided isolated compound from Mangifera indica inhibits 11β-HSD-1 and ameliorates high fat diet-induced diabetes in C57BL/6 mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue, White; Animals; Body Weight; Carbenoxolone; Corticosterone; Diabetes Mellitus, Experimental; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glucose Tolerance Test; Hydrolyzable Tannins; Hypoglycemic Agents; Insulin; Liver; Male; Mangifera; Mice; Mice, Inbred C57BL; Phytotherapy; Plant Leaves | 2013 |
Sex-specific effects of prenatal low-protein and carbenoxolone exposure on renal angiotensin receptor expression in rats.
Topics: Animals; Animals, Newborn; Body Weight; Carbenoxolone; Diet, Protein-Restricted; Female; Kidney; Male; Nephrons; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Sex Characteristics | 2005 |
Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Agouti Signaling Protein; Animals; Atherosclerosis; Blood Pressure; Body Weight; Carbenoxolone; Corticosterone; Energy Metabolism; Fatty Liver; Female; Hyperinsulinism; Hyperlipidemias; Lipoproteins, VLDL; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Receptors, LDL | 2007 |
Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Blood Glucose; Body Weight; Carbenoxolone; Corticosterone; Dietary Fats; Eating; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Mice; Obesity; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Long-term therapy with carbenoxolone in the prevention of recurrence of gastric ulcer. Natural history and evolution of important side-effects and measures to avoid them.
Topics: Adult; Aged; Blood Pressure; Body Weight; Carbenoxolone; Edema; Female; Glycyrrhetinic Acid; Humans; Hypokalemia; Male; Middle Aged; Recurrence; Stomach Ulcer | 1980 |
[Tolerance of carbenoxolone sodium in elderly patients (author's transl)].
Topics: Aged; Body Weight; Carbenoxolone; Drug Tolerance; Female; Heart Failure; Hospitalization; Humans; Hypertension; Hypokalemia; Male; Middle Aged; Peptic Ulcer; Triterpenes | 1977 |
Electrolyte status in duogastrone--treated duodenal ulcer patients.
Topics: Blood Pressure; Body Weight; Carbenoxolone; Duodenal Ulcer; Electrolytes; Female; Glycyrrhetinic Acid; Humans; Male; Middle Aged | 1978 |
The pathogenesis of pseudohyperaldosteronism from carbenoxolone.
Topics: Adult; Aldosterone; Body Weight; Carbenoxolone; Cytosol; Electrolytes; Glycyrrhetinic Acid; Humans; Hydrocortisone; Hyperaldosteronism; Kidney; Male; Mineralocorticoids; Renin; Tetrahydrocortisol; Tetrahydrocortisone | 1989 |